Expert Opinion on Pharmacotherapy, Volume 3, Issue 5 (2002)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 3, Issue 5 (2002)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Volume 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Miscellaneous

Statins: balancing benefits, efficacy and safety
Michael B Clearfield
Pages: 469-477
Published online: 25 Feb 2005
AbstractforStatins: balancing benefits, efficacy and safety | References | PDF (165.2 KB)
  • 55 Views
  • 9 CrossRef citations
  • 0Altmetric
Psychotropic drugs and the ECG: focus on the QTc interval
Paul J Goodnick, Francisco Parra & Jason Jerry
Pages: 479-498
Published online: 25 Feb 2005
AbstractforPsychotropic drugs and the ECG: focus on the QTc interval | References | PDF (271.8 KB)
  • 1484 Views
  • 89 CrossRef citations
  • 0Altmetric
The prevention of sudden death in hypertrophic cardiomyopathy
Bhavesh Sachdev, Perry M Elliott & M Shoaib Hamid
Pages: 499-504
Published online: 25 Feb 2005
AbstractforThe prevention of sudden death in hypertrophic cardiomyopathy | References | PDF (121.1 KB)
  • 32 Views
  • 3 CrossRef citations
  • 0Altmetric
Vasopressin in cardiovascular patients: therapeutic implications
Michael A Zimmerman, Tracy N Albright, Christopher D Raeburn & Craig H Selzman
Pages: 505-512
Published online: 25 Feb 2005
AbstractforVasopressin in cardiovascular patients: therapeutic implications | References | PDF (136.9 KB)
  • 67 Views
  • 9 CrossRef citations
  • 0Altmetric
Immunosuppressive therapy of childhood idiopathic nephrotic syndrome
PA Brogan, RS Trompeter, A Abeyagunawardena & MJ Dillon
Pages: 513-519
Published online: 25 Feb 2005
AbstractforImmunosuppressive therapy of childhood idiopathic nephrotic syndrome | References | PDF (310.2 KB)
  • 50 Views
  • 7 CrossRef citations
  • 0Altmetric
Treatment of malignant hypercalcaemia
P Esbrit & J Hurtado
Pages: 521-527
Published online: 25 Feb 2005
AbstractforTreatment of malignant hypercalcaemia | References | PDF (128.9 KB)
  • 108 Views
  • 23 CrossRef citations
  • 0Altmetric
Thiazolidinediones in the treatment of Type 2 diabetes
Andrew S Greenberg & Anastassios G Pittas
Pages: 529-540
Published online: 25 Feb 2005
AbstractforThiazolidinediones in the treatment of Type 2 diabetes | References | PDF (249.3 KB)
  • 110 Views
  • 23 CrossRef citations
  • 0Altmetric
Update on ocular allergy treatment
Leonard Bielory
Pages: 541-553
Published online: 25 Feb 2005
AbstractforUpdate on ocular allergy treatment | References | PDF (213 KB)
  • 247 Views
  • 49 CrossRef citations
  • 0Altmetric
The pharmacological treatment of anxiety disorders in children and adolescents
Sabine Hack & Lawrence T Nash
Pages: 555-571
Published online: 25 Feb 2005
AbstractforThe pharmacological treatment of anxiety disorders in children and adolescents | References | PDF (254.8 KB)
  • 141 Views
  • 11 CrossRef citations
  • 0Altmetric
The future of pharmacotherapy for paediatric anxiety
Robert L Findling
Pages: 573-574
Published online: 25 Feb 2005
AbstractforThe future of pharmacotherapy for paediatric anxiety | References | PDF (44.5 KB)
  • 19 Views
  • 1 CrossRef citations
  • 0Altmetric
Review of enoxaparin and its clinical applications in venous and arterial thromboembolism
Jacqueline A Mason & Alexander GG Turpie
Pages: 575-598
Published online: 25 Feb 2005
AbstractforReview of enoxaparin and its clinical applications in venous and arterial thromboembolism | References | PDF (843.3 KB)
  • 179 Views
  • 10 CrossRef citations
  • 0Altmetric
Orlistat in the treatment of Type 2 diabetes mellitus
Muna Jneidi & David E Kelley
Pages: 599-605
Published online: 25 Feb 2005
AbstractforOrlistat in the treatment of Type 2 diabetes mellitus | References | PDF (119.8 KB)
  • 66 Views
  • 9 CrossRef citations
  • 0Altmetric
Letrozole in the treatment of breast cancer
Matthew J Ellis & Heather S Shaw
Pages: 607-617
Published online: 25 Feb 2005
AbstractforLetrozole in the treatment of breast cancer | References | PDF (173.3 KB)
  • 36 Views
  • 5 CrossRef citations
  • 0Altmetric
Trizivir
Naiel Nassar & Philip Keiser
Pages: 619-624
Published online: 25 Feb 2005
AbstractforTrizivir | References | PDF (111.1 KB)
  • 65 Views
  • 1 CrossRef citations
  • 0Altmetric
Class benefits of AT1 antagonists in Type 2 diabetes with nephropathy
Sheila A Doggrell
Pages: 625-628
Published online: 25 Feb 2005
AbstractforClass benefits of AT1 antagonists in Type 2 diabetes with nephropathy | References | PDF (70.3 KB)
  • 42 Views
  • 2 CrossRef citations
  • 0Altmetric
The 93rd Annual Meeting of the American Association for Cancer Research
Dietmar W Siemann & J Martin Brown
Pages: 629-632
Published online: 25 Feb 2005
AbstractforThe 93rd Annual Meeting of the American Association for Cancer Research | References | PDF (78.5 KB)
  • 19 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents
Margherita Gobbo et al.
Review Article | Published online: 29 May 2024
A Systematic Review on Safety and Efficacy of Migalastat for the treatment of Fabry’s Disease
Haya Majid et al.
Review Article | Published online: 29 May 2024
Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
Rizwana Parveen et al.
Review Article | Published online: 28 May 2024
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M. Acuña et al.
Review Article | Published online: 28 May 2024
View all latest articles